研究者詳細 - 松尾　俊彦

論文 - 松尾　俊彦

分割表示 141 件中 21 - 40 件目／全件表示 >>

Morphometric Analysis of the Eye by Magnetic Resonance Imaging in MGST2-Gene-Deficient Mice. 査読

Chaomulige, Toshihiko Matsuo, Kohei Sugimoto, Mary Miyaji, Osamu Hosoya, Masashi Ueda, Ryosuke Kobayashi, Takuro Horii, Izuho Hatada

Biomedicines 12 ( 370 ) 1 - 14 2024年1月

[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation]. 査読

Fuminari Fujii, Toshiki Terao, Hisakazu Nishimori, Kentaro Fujii, Toshihiko Matsuo, Tadashi Yoshino, Hiroko Ueda, Tadashi Oyama, Akifumi Matsumura, Kaho Kondo, Chisato Matsubara, Kanako Fujiwara, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Ken-Ichi Matsuoka, Yoshinobu Maeda

[Rinsho ketsueki] The Japanese journal of clinical hematology 65 ( 7 ) 622 - 627 2024年

記述言語：日本語掲載種別：研究論文（学術雑誌）

Relapsed and/or refractory (R/R) primary central nervous system lymphoma (PCNSL) has a poor prognosis. A 57-year-old man diagnosed with PCNSL achieved a complete response by high-dose methotrexate-based chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT). The disease was not cured, so he was treated with the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel after the third relapse. However, the disease relapsed again 28 days after CAR T-cell therapy. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) was attempted as curative therapy after bridging with second ASCT and tirabrutinib monotherapy. Although a temporary response was achieved, the disease relapsed 98 days after allo-HSCT. While receiving tirabrutinib for relapse after allo-HSCT, the patient developed acute respiratory failure due to transplant-related toxicity and post-transplant thrombotic microangiopathy. He died 175 days after allo-HSCT. Although various treatments for PCNSL have been investigated in recent years, the treatment strategy for R/R PCNSL has not been established. Further studies are warranted to improve the outcomes of patients with R/R PCNSL.

DOI： 10.11406/rinketsu.65.622

PubMed

researchmap

特集指定難病 Up to Date 網膜色素変性症招待査読

松尾俊彦

岡山医学会雑誌 135 ( 3 ) 147 - 151 2023年12月

Nontuberculous mycobacterial abscess of lacrimal sac and eyelid debridement: Case report 査読

Toshihiko Matsuo, Takehiro Tanaka, Kiyoshi Yamada, Motoko Nose, Yasushi Tanimoto

Clinical Case Reports 11 ( e8364 ) 1 - 6 2023年12月

A simple method for culturing Acanthamoeba from soft contact lens at a clinical laboratory of a hospital: Case report of Acanthamoeba keratitis. 査読

Toshihiko Matsuo, Motoko Nose

Clinical Case Reports 11 ( e8248 ) 1 - 5 2023年11月

Resection of Orbital Myxoma With Magnetic Resonance Imaging Evidence of Ethmoid Sinus Origin: Case Report and Review of 20 Patients in the Literature. 査読

Toshihiko Matsuo, Takehiro Tanaka

Journal of Investigative Medicine High Impact Case Reports 11 ( 10.1177/23247096231201013 ) 1 - 6 2023年9月

Bilateral lacrimal gland mantle cell lymphoma in 11-year follow-up: case report and review of 48 cases with ocular adnexal presentation in the literature. 査読

Toshihiko Matsuo, Takehiro Tanaka, Kazuya Okada, Kenji Notohara, Keiko Fujii, Nobuharu Fujii

Journal of Investigative Medicine High Impact Case Reports 11 ( 23247096231185483 ) 2023年7月

Bilateral Optic Neuritis and Hypophysitis With Diabetes Insipidus 1 Month After COVID-19 mRNA Vaccine: Case Report and Literature Review 査読

Toshihiko Matsuo, Kohei Okubo, Hirofumi Mifune, Takeshi Imao

Journal of Investigative Medicine High Impact Case Reports 11 ( 23247096231186046 ) 1 - 10 2023年7月

ANCA-associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature review 査読

Toshihiko Matsuo, Sumie Hiramatsu-Asano, Hiroshi Sawachika, Hirotake Nishimura

Clinical Case Reports 11 ( e7595 ) 1 - 8 2023年6月

両側涙腺原発マントル細胞リンパ腫に対する末梢血幹細胞移植後10年診た1例

松尾俊彦, 田中健大, 岡田和也, 能登原憲司, 藤井敬子, 藤井伸治

日本リンパ網内系学会会誌 63 126 - 126 2023年6月

Revisitng cyptocyanine dye, NK-4, as an old and new drug: review and future perspectives. 査読

Shuihui Liu, Toshihiko Matsuo, Takumi Abe

Internnational Journal of Molecular Sciences 24 ( 4411 ) 1 - 14 2023年2月

Revisiting Cryptocyanine Dye, NK-4, as an Old and New Drug: Review and Future Perspectives

Shihui Liu, Toshihiko Matsuo, Takumi Abe

International Journal of Molecular Sciences 2023年2月

Are Prophylactic Systemic Antibiotics Required in Patients with Cataract Surgery at Local Anesthesia? 査読

Toshihiko Matsuo, Masahiro Iguchi, Noriyasu Morisato, Tatsuya Murasako, Hideharu Hagiya

International Journal of Environmental Research and Public Health 19 ( 15796 ) 1 - 8 2022年11月

Temporal association of vitreous hemorrhage and hypertension after COVID- 19 mRNA vaccines. 査読

Toshihiko Matsuo, Hiroshi Noda

Clinical Case Reports 10 ( e06657 ) 1 - 3 2022年11月

Traditional Chinese Medicines and Prescriptions Brought from China to Japan by a Monk (Jianzhen, Japanese: Ganjin): A Historical Review. 査読

Shihui Liu, Toshihiko Matsuo, Chie Matsuo, Takumi Abe

Compounds 2 ( 4 ) 267 - 284 2022年10月

Diffuse large B-cell lymphoma in the course of systemic sarcoidosis: A case report and review of 30 Japanese patients with sarcoidosis-lymphoma syndrome. 査読

Toshihiko Matsuo, Takehiro Tanaka, Rika Omote, Toshiaki Okada, Kenji Notohara, Kazuya Okada

Journal of Clinical and Experimental Hematopathology 62 ( 4 ) 22 - 237 2022年9月

Candidate Genes in Testing Strategies for Linkage Analysis and Bioinformatic Sorting of Whole Genome Sequencing Data in Three Small Japanese Families with Idiopathic Superior Oblique Muscle Palsy. 査読

Toshihiko Matsuo, Chaomulige, Mary Miyaji, Osamu Hosoya, Akira Saito, Kazuyuki Nakazono

International Journal of Molecular Sciences 23 ( 8626 ) 1 - 16 2022年8月

CD19 immunostaining of a stored paraffin-embedded vitrectomy cell block of intraocular lymphoma contributing to chimera antigen receptor T-cell therapy. 査読

Matsuo T, Tanaka T, Fujii N, Fujii K, Kondo E

Journal of Clinical and Experimental Hematopathology 62 ( 3 ) 187 - 189 2022年8月

Photorefraction with Spot Vision Screener Versus Visual Acuity Testing as Community-Based Preschool Vision Screening at the Age of 3.5 Years in Japan

Toshihiko Matsuo, Chie Matsuo, Masami Kayano, Aya Mitsufuji, Chiyori Satou, Hiroaki Matsuoka

International Journal of Environmental Research and Public Health 19 ( 8655 ) 1 - 15 2022年7月

人工臓器の最前線vol.3「光電変換色素薄膜型の人工網膜OUReP（オーレップ）招待

松尾俊彦, 内田哲也, 石金浩史

医学のあゆみ 282 ( 4 ) 304 - 312 2022年7月

　前のページ - 次のページ　

<松尾 俊彦>

論文 - 松尾 俊彦

<松尾　俊彦>

論文 - 松尾　俊彦